Literature DB >> 18043542

Radionuclide production and yields at Washington University School of Medicine.

L Tang1.   

Abstract

Washington University School of Medicine has carried out the production of ''non-standard'' nuclides for the positron emission tomography (PET) community since 1999 under the Radionuclide Resource for Cancer Applications grant R24 CA 86307 funded by the National Cancer Institute. With the support from the grant, we have successfully developed procedures for the high yield production of a wide range of radionuclides and made them available to the research community. The following non-standard PET nuclides, (60)Cu, (61)Cu, (64)Cu, (76)Br, (77)Br, (124)I, (94m)Tc, and (86)Y are routinely produced on Washington University on-site Cyclotron Corporation CS-15 or Japan Steel Works 16/8 cyclotrons. Additionally, a technique to produce (45)Ti has been developed and lately, (89)Zr is being investigated. This paper describes the production techniques and presents the performance results in terms of yields and radionuclidic purity. Sufficient yields for distribution are achieved and high radionuclide purity is also achieved yielding high quality product for medical research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043542

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  7 in total

Review 1.  PET tracers based on Zirconium-89.

Authors:  Yin Zhang; Hao Hong; Weibo Cai
Journal:  Curr Radiopharm       Date:  2011-04

Review 2.  Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications.

Authors:  Yongjian Liu; Michael J Welch
Journal:  Bioconjug Chem       Date:  2012-02-06       Impact factor: 4.774

3.  Evaluation of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursors.

Authors:  Dong Zhou; Sung Hoon Kim; Wenhua Chu; Thomas Voller; John A Katzenellenbogen
Journal:  J Labelled Comp Radiopharm       Date:  2017-06-14       Impact factor: 1.921

4.  Bromination from the macroscopic level to the tracer radiochemical level: (76)Br radiolabeling of aromatic compounds via electrophilic substitution.

Authors:  Dong Zhou; Haibing Zhou; Carl C Jenks; Jason S Lewis; John A Katzenellenbogen; Michael J Welch
Journal:  Bioconjug Chem       Date:  2009-04       Impact factor: 4.774

5.  Copper-Mediated Nucleophilic Radiobromination of Aryl Boron Precursors: Convenient Preparation of a Radiobrominated PARP-1 Inhibitor.

Authors:  Dong Zhou; Wenhua Chu; Thomas Voller; John A Katzenellenbogen
Journal:  Tetrahedron Lett       Date:  2018-04-11       Impact factor: 2.415

6.  Synthesis and Biological Evaluation of (S)-Amino-2-methyl-4-[(76)Br]bromo-3-(E)-butenoic Acid (BrVAIB) for Brain Tumor Imaging.

Authors:  Jennifer L Burkemper; Chaofeng Huang; Aixiao Li; Liya Yuan; Keith Rich; Jonathan McConathy; Suzanne E Lapi
Journal:  J Med Chem       Date:  2015-10-20       Impact factor: 7.446

7.  Improved production of 76Br, 77Br and 80mBr via CoSe cyclotron targets and vertical dry distillation.

Authors:  Paul A Ellison; Aeli P Olson; Todd E Barnhart; Sabrina L V Hoffman; Sean W Reilly; Mehran Makvandi; Jennifer L Bartels; Dhanabalan Murali; Onofre T DeJesus; Suzanne E Lapi; Bryan Bednarz; Robert J Nickles; Robert H Mach; Jonathan W Engle
Journal:  Nucl Med Biol       Date:  2019-09-05       Impact factor: 2.947

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.